Bhuiyan Mohammed Saiful Islam, Noor Towhida, Akhter Sania, Tahnin Nur-A-Tasmin, Bouazzi Dorra, Medianfar Cecilia E, Christensen Robin, Jemec Gregor B E
Department of Dermatology and Venereology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.
Department of Dermatology and Venereology, Metador Diagnostic and Wellness Center, Dhaka, Bangladesh.
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000538444.
BACKGROUND: The prevalence of hidradenitis suppurativa (HS) varies widely in different epidemiologic studies from different parts of the world and very few data are available from South Asia. OBJECTIVES: The aim of this study was to determine the prevalence of HS in Dhaka, Bangladesh. METHODS: An exploratory, cross-sectional, and descriptive study was done among 2,500 consecutive healthy accompanying adults of patients attending at the outpatient department (except dermatology), at the Bangabandhu Sheikh Mujib Medical University Hospital, Dhaka, Bangladesh. This was an initiative of Global Hidradenitis Suppurativa Atlas (GHiSA), and it therefore followed the approach previously published by Bouazzi et al. Results: Out of a total of 2,377 accompanying persons, 3 were diagnosed with HS. The point prevalence was 0.13% (CI: 0.04%-0.37%), sensitivity was 0.1 (3/3), specificity was 0.1 (23/23), positive predictive value positive predictive value (PPV) was 0.1 (3/3), and the negative predictive value was 0.1 (23/23). The median age of the HS patients was 45.0, and the median BMI was 28.0. All 3 confirmed HS were male. CONCLUSIONS: The prevalence of HS in Bangladesh is lower than in western countries and other GHiSA studies like Singapore, Ghana, and Greenland.
背景:在来自世界不同地区的不同流行病学研究中,化脓性汗腺炎(HS)的患病率差异很大,而南亚地区的数据非常少。 目的:本研究旨在确定孟加拉国达卡HS的患病率。 方法:在孟加拉国达卡的班加班杜·谢赫·穆吉布医科大学医院门诊部(皮肤科除外)对2500名连续就诊患者的健康陪同成年人进行了一项探索性、横断面描述性研究。这是全球化脓性汗腺炎地图集(GHiSA)的一项举措,因此遵循了Bouazzi等人先前发表的方法。结果:在总共2377名陪同人员中,有3人被诊断为HS。点患病率为0.13%(CI:0.04%-0.37%),敏感性为0.1(3/3),特异性为0.1(23/23),阳性预测值(PPV)为0.1(3/3),阴性预测值为0.1(23/23)。HS患者的中位年龄为45.0,中位BMI为28.0。所有3例确诊的HS患者均为男性。 结论:孟加拉国HS的患病率低于西方国家以及其他GHiSA研究(如新加坡、加纳和格陵兰)。
Dermatology. 2025-7-7
Dermatology. 2025-7-7
Dermatology. 2025-7-7
Br J Dermatol. 2022-10
Australas J Dermatol. 2021-11
J Patient Exp. 2021-4-13
Br J Dermatol. 2020-12
Int J Womens Dermatol. 2019-7-2